K-679

N/A

Report date: 2025/07/04 14:44:48

Base Information

Drug NameK-679

Drug Alias NameK-679

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > DM1 payload +[4]

Mechanisms of ActionAnti-Epidermal growth factor receptor erbB1Tubulin inhibitors

TargetsEpidermal growth factor receptor erbB1Tubulin

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKowa Dental Health Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesKowa Dental Health Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A